(Q38066210)

28 August 2017

Treating renal anaemia with recombinant human erythropoietin: practical guidelines and a clinical algorithm (English)

1 reference

28 August 2017

1 reference

Macdougall IC

1

1 reference

28 August 2017

Hutton RD

2

1 reference

28 August 2017

Cavill I

3

1 reference

28 August 2017

Coles GA

4

1 reference

28 August 2017

Williams JD

5

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 March 1990

1 reference

28 August 2017

5

1 reference

inferred from page(s)

published in

The BMJ

1 reference

28 August 2017

300

1 reference

28 August 2017

6725

1 reference

28 August 2017

655-659

1 reference

Effect of parathyroid hormone on erythropoiesis

28 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662415

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662415

Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662415

Management of blood pressure changes during recombinant human erythropoietin therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662415

The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662415

Adverse effects of therapy for the correction of anemia in hemodialysis patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662415

Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662415

Hypertension, blood viscosity, and cardiovascular morbidity in renal failure: implications of erythropoietin therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662415

Recombinant human erythropoietin: implications for nephrology

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662415

The therapeutic equivalence of oral and intravenous iron in renal dialysis patients

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662415

Blood rheology and hypertension in hemodialysis patients treated with erythropoietin.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662415

Treatment of the anemia of predialysis patients with recombinant human erythropoietin: a randomized, placebo-controlled trial.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662415

Prospective evaluation of a monoclonal antibody in diagnosis of Pneumocystis carinii pneumonia.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662415

Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662415

Recombinant human erythropoietin therapy in haemodialysis patients--dose determination and clinical experience

31 August 2018

1 reference

12 December 2020

Subcutaneous erythropoietin

1 reference

12 December 2020

Working capacity is increased following recombinant human erythropoietin treatment

1 reference

12 December 2020

Intraperitoneal erythropoietin

1 reference

12 December 2020

Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial

1 reference

12 December 2020

Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Erythropoietin treatment: influence of haemoglobin concentration on dialyser creatinine clearance in haemodialysed patients

1 reference

12 December 2020

Iron status in patients receiving erythropoietin for dialysis-associated anemia

1 reference

12 December 2020

Subcutaneous erythropoietin and peritoneal dialysis

1 reference

12 December 2020

Intraperitoneal erythropoietin

1 reference

12 December 2020

Treatment of the anemia of progressive renal failure with recombinant human erythropoietin

1 reference

12 December 2020

Haemostatic effects of recombinant human erythropoietin in chronic haemodialysis patients

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of renal anemia with recombinant human erythropoietin

1 reference

12 December 2020

Experience with daily self-administered subcutaneous erythropoietin

1 reference

12 December 2020

Erythropoietin levels in uremic nephric and anephric patients

1 reference

12 December 2020

Influence of continuous ambulatory peritoneal dialysis on the anemia of endstage renal disease

1 reference

12 December 2020

Hemodialysis and continuous ambulatory peritoneal dialysis effects on erythropoiesis in renal failure

1 reference

12 December 2020

Estimates of iron sufficiency in the US population

1 reference

12 December 2020

USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patients

1 reference

12 December 2020

Subcutaneous recombinant erythropoietin in the treatment of renal anaemia in CAPD patients

1 reference

12 December 2020

Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients

1 reference

12 December 2020

THE DIAGNOSIS OF IRON DEFICIENCY ANEMIA

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.300.6725.655

1 reference

28 August 2017

1 reference

28 August 2017

PubMed publication ID

2322705

1 reference